Susan Halabi on Sub Group Analysis
March 14, 2017
Susan Halabi, PhD, is Professor, Department of Biostatistics and Bioinformatics, Duke University and Faculty Statistician, Genitourinary Committee (GU), for the Alliance for Clinical Trials in Oncology (formerly the Cancer and Leukemia Group B), an National Cancer Institute (NCI)-sponsored cancer cooperative group. She is actively involved in clinical trial design, conduct and analysis, and biomarker validation and has published over 140 articles in medical and statistical journals. In addition, she has extensive experience and maintains a research portfolio in model development, validation and exploring surrogate endpoints of overall survival in prostate and renal cancer. She has been a member of the NCI GU Steering Committee since its inception in 2008 and is a member of the Renal, Bladder and Prostate Task Forces. Dr. Halabi has served on study sections and review committees for the NCI, other NIH institutes and the Food and Drug Administration, and has also served as an officer for the International Biometric Society, the American Statistical Association, and the Society of Clinical Trials.
Access to all Advanced Prostate Cancer Consensus Conference Video Coverage
Read the 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer